Indraprastha Medical Corporation Limited (INDRAMEDCO)

Loading page…

Indraprastha Medical Corporation Limited (INDRAMEDCO) · mywealthgrid

About

Hospital operator in India's healthcare sector. ₹3,424 Cr market cap, ₹400 Cr quarterly revenue, 18% operating margins, zero debt. Annual dividend payments and 51% promoter holding reflect stable capital structure.

Face value: ₹10

Market cap

₹3,105 Cr

P/E

16.5×

P/B

4.2×

Dividend yield

1.2%

ROE

27.5%

ROCE

33.7%

Debt / equity

OPM

18%

EPS (TTM)

₹20.5

Book value

₹80.8

52-week high

—

52-week low

Key insights

Company research notes and source-linked reviews

Key risks

Stock down 19% YoY despite consistent quarterly profitability — verify whether market reflects demand softness, competitive pressure, or prior growth expectations reset
OPM range 16–20% and EPS swings ₹3.58–₹6.09 signal earnings inconsistency — check occupancy trends, case-mix pricing, and quarterly cost drivers
FII holding at 2.77% while DII minimal (0.59%) suggests limited institutional participation — verify if valuation or transparency concerns deter institutions
Healthcare regulation on pricing, staffing, and capacity varies by state — track recent rate-setting or licensing changes in operating geographies

Generated analysis · source review pending

Growth drivers

Revenue grew ₹324.93 Cr (Dec 2024) to ₹406.15 Cr (Jun 2026) — verify if organic volume/pricing growth or new facilities/capacity additions drove expansion
OPM expanded to 19.65% (Jun 2026), highest in dataset, from 16% floor — if sustained reflects operational efficiency or scale benefits
Zero debt (D/E 0) with 27.47% ROE enables capex-funded organic expansion — verify how management allocates retained earnings toward greenfield or new hospital builds
Strong cash generation on ₹406 Cr quarterly revenue with 18% margins supports reinvestment — track capex trajectory and organic growth rate

Generated analysis · source review pending

2,528 historical price candles were omitted because the exchange source has not been verified.

₹338.6-4.6%1Y

Quick read

rule-based

Pros

+Strong return on equity of 28.8% (3-yr avg)
+High return on capital employed of 34.8%
+Profit CAGR of 139.5% over the last 5 years
+Revenue CAGR of 19.3% over the last 5 years
+Almost debt-free (debt/equity 0)
+Comfortable interest coverage of 41.9×

Cons

No red flags triggered.

Research score

Structured signal from quality, growth, valuation and momentum.

72/100

Business quality: 86
Growth: 58
Valuation

Revenue & net profit

₹ crore, by fiscal year

RevenuePAT

Margins

% of revenue, by fiscal year

OPMPAT margin

Peers

Comparable companies from the narrowest available industry classification.

Screen this industry Compare top 5 side-by-side

Loading peers…

Financials

Reported profit and loss, balance sheet, cash flow and growth history.

Annual Quarterly

Standalone figures · ₹ crore · years without a filed annual are summed from quarters

₹ Cr	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	733	767	748	788	831	613	888	1,099	1,245	1,356	1,483
COGS	-152	-151	140	145	152	114	174	194	217	230	256
Gross profit	—	—	609	643	679	500	714	905	1,028	1,126	1,226
	834	839	537	562	593	459	600	754	834	882	959
	51	79	72	81	86	40	114	151	193	244	267
OPM %	7%	10.3%	9.6%	10.3%	10.4%	6.6%	12.9%	13.7%	15.5%	18%	18%
Depreciation	27	31	31	30	33	33	35	39	40	44	44
Interest	7	8	9	7	6	3	3	4	4	6	6
	2	2	2	0	1	1	3	10	17	23	29
Profit before tax	44	42	34	45	48	4	79	117	166	216	246
Tax	16	15	13	16	5	2	20	31	42	55	62
Tax %	36.6%	35.7%	37.9%	36.3%	9.5%	45.7%	25.9%	26.5%	25.4%	25.6%	25.4%
	28	27	21	28	44	2	59	86	124	161	184
PAT margin %	3.9%	3.5%	2.8%	3.6%	5.3%	0.4%	6.6%	7.8%	10%	11.9%	12.4%
EPS (₹)	—	2.9	2.3	3.1	4.8	0.3	6.4	9.4	13.5	17.6	20
EPS adjusted (₹)	—	—	—	3.1	4.8	0.3	6.4	9.4	13.5	17.6	20
	—	61.2%	65.2%	51.6%	0%	0%	39.1%	31.9%	33.3%	25.6%	20%
Annual report	Annual report for Mar 2016	Annual report for Mar 2017	Annual report for Mar 2018	Annual report for Mar 2019	Annual report for Mar 2020	Annual report for Mar 2021	Annual report for Mar 2022	Annual report for Mar 2023	Annual report for Mar 2024	Annual report for Mar 2025	—

₹ Cr	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity capital	92	92	92	92	92	92	92	92
Reserves	—	176	181	234	288	386	505	649
	—	4	0	0	0	0	0	0
	—	177	159	136	176	245	255	251
Total equity & liabilities	—	449	432	462	555	723	852	991
	280	303	283	277	275	347	328	365
CWIP	—	0	3	0	3	0	33	3
Investments	—	0	0	0	0	0	0	0
	—	146	145	185	278	376	491	624
Total assets	—	449	432	462	555	723	852	991

Loading financials…

Ratios

Annual operating, return, leverage and working-capital ratios.

Standalone figures

Ratio	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Margins
Gross margin %	81.6%	81.8%	81.4%	80.4%	82.4%	82.6%	83%	82.7%
EBITDA margin %	10.3%	10.4%	6.6%	12.9%	13.7%	15.5%	18%	18%
EBIT margin %	6.5%	6.4%	1.1%	8.9%	10.1%	12.3%	14.7%	15.1%
PAT margin %	3.6%	5.3%	0.4%	6.6%	7.8%	10%	11.9%	12.4%
Working capital
Receivable days	—	35	40	18	23	17	20	28
Inventory days	—	29	28	21	16	13	11	11
Payable days	—	250	294	161	185	235	194	182
NWC days	—	-186	-226	-122	-146	-205	-163	-144
Leverage
Current ratio	—	1.01	1.22	1.68	1.72	1.86	2.41	2.46
Debt to EBITDA	—	0.05	0	0	0	0	0	0
Debt to equity	—	0.01	0	0	0	0	0	0
Interest coverage	7.5	9.1	2.3	24.2	28.4	41.9	35.5	41.9
Asset turnover	—	1.85	1.42	1.92	1.98	1.72	1.59	1.5
Return ratios
Return on assets %	—	9.7%	0.5%	12.7%	15.5%	17.1%	18.9%	18.5%
Return on capital employed %	—	17.5%	2.4%	24.1%	30.6%	34.6%	36.2%	33.7%
Return on equity %	—	16.3%	0.9%	18%	22.7%	25.9%	27%	24.8%

Derived from reported annual statements. ROCE uses EBIT over capital employed (total assets less current liabilities). Day counts average the opening and closing balance; receivables turn on revenue, inventory and payables on cost of goods sold.

Loading ratios…

Shareholding

Quarterly ownership, named holders, insider transactions and disclosed deals.

Quarterly Annual

Every quarter filed · % of equity

Holder (%)	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	51%	51%	51%	51%	51%	51%	51%	51%	51%	51%	51%	51%
	0.8%	0.95%	1.08%	1.7%	2.64%	2.88%	2.94%	2.72%	2.41%	2.73%	2.44%	2.77%
	6.71%	6.37%	4.91%	3.15%	3.2%	3.19%	3.56%	3.56%	3.51%	0.83%	0.88%	0.59%
	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
	41.49%	41.68%	43.01%	44.15%	43.16%	42.93%	42.5%	42.72%	43.08%	45.44%	45.68%	45.64%
No. of shareholders	—	—	—	—	—	—	—	—	70,914	71,225	72,980	75,098

Promoter holding up 0 percentage points since Sep 2023.

7 deals · 22 Apr 2024 – 8 Oct 2025

Date	Client	Type	Venue	Side	Quantity	Price	Value
8 Oct 2025	GRAVITON RESEARCH CAPITAL LLP	Bulk	NSE	Buy	12,32,834	₹587.07	₹72.38 Cr
8 Oct 2025	GRAVITON RESEARCH CAPITAL LLP	Bulk	NSE	Sell	12,32,350	₹586.98	₹72.34 Cr
7 Oct 2025	SWAY FINANCIAL SERVICES	Bulk	NSE	Buy	4,87,634	₹555.26	₹27.08 Cr
7 Oct 2025	SWAY FINANCIAL SERVICES	Bulk	NSE	Sell	9,294	₹512.53	₹0.48 Cr
7 Aug 2024	GRAVITON RESEARCH CAPITAL LLP	Bulk	NSE	Sell	5,41,765	₹327.42	₹17.74 Cr
7 Aug 2024	GRAVITON RESEARCH CAPITAL LLP	Bulk	NSE	Buy	5,41,765	₹327.06	₹17.72 Cr
22 Apr 2024	QUANT MUTUAL FUND - QUANT SMALL CAP FUND	Bulk	NSE	Buy	5,50,000	₹249.59	₹13.73 Cr

1–7 of 7

1 / 1

Bulk deals are a client trading over 0.5% of the equity in a session, aggregated across their trades; block deals are single negotiated trades in the exchange’s block window. Each is reported by the exchange it was crossed on, so NSE and BSE rows are separate trades rather than the same trade twice.

Mr. Pratap C ReddyNon-Executive - Non Independent Director-Chairperson related to Promoter
C P TyagiChief Financial Officer
Mrs. Suneeta ReddyNon-Executive - Non Independent Director
Mrs. Sangita ReddyNon-Executive - Non Independent Director
Ms. Madhumita GanguliNon-Executive - Independent Director
Mr. Mahesh VermaNon-Executive - Non Independent Director
Mr. Salil SinghalNon-Executive - Independent Director
Mrs. Vineeta RaiNon-Executive - Independent Director
Mr. Tejpreet Singh ChopraNon-Executive - Independent Director
Mr. Sandip SomanyNon-Executive - Independent Director
Mr. Sudhir JalanNon-Executive - Independent Director

Loading shareholding…

F&O

Current futures and options contracts with compact option-chain pages.

Not in the F&O segment

Only about 210 stocks have listed futures and options. Contracts appear here for those, refreshed after each close.

Loading f&o…

Fund holders

Mutual-fund schemes that disclosed a holding in the company.

Portfolio month

Schemes holding

across 2 fund houses

Held by these funds

0.03%

of the company's equity

All mutual funds

0.01%

shareholding pattern, Jun 2026

Portfolios as of

August 2026

compared with July 2026

3 schemes · 2 fund houses

		Shares
IB63-Groww BSE Hospitals ETF	Groww Mutual Fund	29,503	1.07	0.68%	0.032%	+5,946
(Investment Manager for Motilal Oswal Mutual Fund)	Motilal Oswal Mutual Fund	1,207	0.04	0.1%	0.001%	+2
(Investment Manager for Motilal Oswal Mutual Fund)	Motilal Oswal Mutual Fund	131	0	0.01%	0%	+1

Loading fund holders…

Documents

Annual reports, exchange filings, offer documents, ratings and earnings-call material.

Announcements

Loading documents…

Events

Upcoming dates and the company’s corporate-action history.

18

Final dividend18 Sept 2026 · ex-date₹4
Final dividend18 Sept 2025 · ex-date₹4.5
Final dividend13 Sept 2024 · ex-date₹4.5
Dividend dividend15 Sept 2023 · ex-date₹3
Dividend dividend15 Sept 2022 · ex-date₹2.5
Dividend dividend12 Sept 2019 · ex-date₹1.6
Dividend dividend12 Sept 2018 · ex-date₹1.5
Dividend dividend14 Sept 2017 · ex-date₹1.8
Dividend dividend18 Aug 2016 · ex-date₹1.8
Dividend dividend16 Sept 2015 · ex-date₹1.8
Dividend dividend18 Sept 2014 · ex-date₹1.8
Dividend dividend19 Sept 2013 · ex-date₹1.6
Dividend dividend6 Sept 2012 · ex-date₹1.6
Dividend dividend5 Sept 2011 · ex-date₹1.6
Dividend dividend30 Aug 2010 · ex-date₹1.6
Dividend dividend27 Aug 2009 · ex-date₹1.5
Dividend dividend28 Aug 2008 · ex-date₹1.4
Dividend dividend7 Sept 2007 · ex-date₹1.25

1

Board meeting to consider results6 Aug 2026

Loading events…

Announcements

Latest exchange announcements, filings and downloadable documents.

1 month 3 months 6 months 1 year All

9 announcementsExport CSV

22 Sept 2026, 3:05 pmInsider Trading / SAST

Closure of Trading Window

Closure of Trading Window PDF

Loading announcements…

Ratio	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Margins
Gross margin %	81.6%	81.8%	81.4%	80.4%	82.4%	82.6%	83%	82.7%
EBITDA margin %	10.3%	10.4%	6.6%	12.9%	13.7%	15.5%	18%	18%
EBIT margin %	6.5%	6.4%	1.1%	8.9%	10.1%	12.3%	14.7%	15.1%
PAT margin %	3.6%	5.3%	0.4%	6.6%	7.8%	10%	11.9%	12.4%
Working capital
Receivable days	—	35	40	18	23	17	20	28
Inventory days	—	29	28	21	16	13	11	11
Payable days	—	250	294	161	185	235	194	182
NWC days	—	-186	-226	-122	-146	-205	-163	-144
Leverage
Current ratio	—	1.01	1.22	1.68	1.72	1.86	2.41	2.46
Debt to EBITDA	—	0.05	0	0	0	0	0	0
Debt to equity	—	0.01	0	0	0	0	0	0
Interest coverage	7.5	9.1	2.3	24.2	28.4	41.9	35.5	41.9
Asset turnover	—	1.85	1.42	1.92	1.98	1.72	1.59	1.5
Return ratios
Return on assets %	—	9.7%	0.5%	12.7%	15.5%	17.1%	18.9%	18.5%
Return on capital employed %	—	17.5%	2.4%	24.1%	30.6%	34.6%	36.2%	33.7%
Return on equity %	—	16.3%	0.9%	18%	22.7%	25.9%	27%	24.8%

Company	Mkt Cap	EV	Revenue	EBITDA	OPM	PAT	NPM	ROCE	ROE	WC Days
Max Healthcare Institute LimitedMAXHEALTHMAXHEALTH	₹91,573 Cr	₹95,052 Cr	₹8,712 Cr	₹2,318 Cr	26.8%	₹1,457 Cr	17.2%	13.8%	14.3%	-110
Manipal Health Enterprises LimitedMANIPALHOSMANIPALHOS	₹91,552 Cr	₹1,02,105 Cr	₹10,336 Cr	₹2,611 Cr	25.3%	₹917 Cr	8.9%	12.5%	12.8%	38
Fortis Healthcare LimitedFORTISFORTIS	₹59,268 Cr	₹62,140 Cr	₹9,506 Cr	₹2,131 Cr	22.8%	₹1,048 Cr	11.7%	13%	11.1%	-99
Aster Dm Healthcare LimitedASTERDMASTERDM	₹36,728 Cr	₹37,429 Cr	₹4,876 Cr	₹958 Cr	19.4%	₹319 Cr	9.2%	11.9%	9.7%	-112
Global Health LimitedMEDANTAMEDANTA	₹36,498 Cr	₹37,688 Cr	₹4,683 Cr	₹979 Cr	20.8%	₹556 Cr	12.6%	16.9%	15.1%	-26
Narayana Hrudayalaya Ltd.NHNH	₹35,594 Cr	₹40,460 Cr	₹9,072 Cr	₹1,749 Cr	20.5%	₹816 Cr	10.2%	15.1%	19.7%	-181
Krishna Institute Of Medical Sciences LimitedKIMSKIMS	₹29,457 Cr	₹32,701 Cr	₹4,213 Cr	₹833 Cr	20.5%	₹205 Cr	6.2%	9.5%	11%	-50
Dr. Agarwal's Health Care LimitedAGARWALEYEAGARWALEYE	₹15,420 Cr	₹15,578 Cr	₹2,207 Cr	₹612 Cr	27.4%	₹148 Cr	8.1%	10.1%	6.8%	-76
Rainbow Childrens Medicare LimitedRAINBOWRAINBOW	₹13,003 Cr	₹13,003 Cr	₹1,820 Cr	₹575 Cr	32%	₹285 Cr	16.5%	18.2%	17.9%	-73
Park Medi World LimitedPARKHOSPSPARKHOSPS	₹11,696 Cr	₹11,924 Cr	₹1,679 Cr	₹444 Cr	26.5%	₹258 Cr	16.3%	21.4%	16.7%	-2
Healthcare Global Enterprises LimitedHCGHCG	₹9,984 Cr	₹10,895 Cr	₹2,627 Cr	₹480 Cr	18.3%	₹23 Cr	0.9%	9.1%	1.2%	-93
Yatharth Hospital & Trauma Care Services LimitedYATHARTHYATHARTH	₹9,965 Cr	₹10,218 Cr	₹1,334 Cr	₹310 Cr	24.2%	₹174 Cr	14.1%	12.3%	10%	-26

Date	Category	Subject	Filing
22 Sept 2026, 3:05 pm	Insider Trading / SAST Closure of Trading Window	Closure of Trading Window	PDF
15 Sept 2026, 4:10 pm	Company Update Newspaper Publication	Announcement under Regulation 30 (LODR)-Newspaper Publication	PDF
3 Sept 2026, 12:20 pm	Company Update Newspaper Publication	Announcement under Regulation 30 (LODR)-Newspaper Publication	PDF
1 Sept 2026, 12:46 pm	Others Reg. 34 (1) Annual Report	Reg. 34 (1) Annual Report.	PDF
1 Sept 2026, 12:41 pm	AGM/EGM AGM	Annual General Meeting On 24Th September, 2026	PDF
29 Aug 2026, 4:08 pm	Company Update General	Annual General Meeting Of The Members Of The Company, Record Date For Dividend And Cut-Off Date For Remote E-Voting.	PDF
7 Aug 2026, 12:51 pm	Company Update Newspaper Publication	Announcement under Regulation 30 (LODR)-Newspaper Publication	PDF
27 Jul 2026, 1:28 pm	Board Meeting	Board Meeting Intimation for Intimation Of Board Meeting	PDF

₹ Cr	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	75	86	28	71	144	200	157	167
	-17	-40	-20	-51	-108	-158	-111	-178
	-44	-43	-3	-3	-26	-32	-46	-46
Net cash flow	14	4	5	17	11	9	-0	-57
Free cash flow	58	46	7	42	100	131	120	108
CFO / Operating profit %	93.1%	100.1%	69.3%	62.4%	95.9%	103.5%	64.2%	62.7%

Indraprastha Medical Corporation Limited

About

Key insights

Key risks

Growth drivers

Quick read

Pros

Cons

Research score

Revenue & net profit

Margins

Peers

Financials

Ratios

Shareholding

F&O

Not in the F&O segment

Fund holders

Documents

Announcements

Events

18

1

Announcements

18

1

Not in the F&O segment

Announcements

Annual reports

Credit ratings

Compounded sales growth

Compounded profit growth

Return on equity

Indraprastha Medical Corporation Limited

About

Key insights

Key risks

Growth drivers

Quick read

Pros

Cons

Research score

Revenue & net profit

Margins

Peers

Financials

Profit & loss

Balance sheet

Ratios

Ratio timeline

Shareholding

Quarterly record

Bulk & block deals

Board and management

F&O

Not in the F&O segment

Fund holders

Documents

Announcements

Events

Dividends18

Board meetings1

Announcements

Dividends18

Board meetings1

Ratio timeline

Not in the F&O segment

Quarterly record

Bulk & block deals

Board and management

Announcements

Annual reports

Credit ratings

Profit & loss

Balance sheet

Cash flow

Compounded returns

Compounded sales growth

Compounded profit growth

Return on equity

18

1

18

1